Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,773 | 99 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $518.02 | 34 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $163.48 | 4 | $0 (2019) |
| PFIZER INC. | $143.72 | 14 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $115.22 | 2 | $0 (2018) |
| UroGen Pharma, Inc. | $110.51 | 6 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $99.60 | 5 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $80.97 | 1 | $0 (2017) |
| Blue Earth Diagnostics Limited | $72.74 | 3 | $0 (2021) |
| UROVANT SCIENCES INC | $70.14 | 4 | $0 (2022) |
| Amgen Inc. | $69.25 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.91 | 1 | AbbVie Inc. ($19.91) |
| 2022 | $294.55 | 22 | PFIZER INC. ($130.15) |
| 2021 | $197.03 | 12 | Blue Earth Diagnostics Limited ($51.49) |
| 2020 | $50.88 | 3 | Astellas Pharma US Inc ($50.88) |
| 2019 | $236.38 | 10 | Astellas Pharma US Inc ($166.39) |
| 2018 | $415.37 | 22 | Astellas Pharma US Inc ($106.18) |
| 2017 | $558.84 | 29 | Astellas Pharma US Inc ($177.76) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2021 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/12/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: UROLOGY | ||||||
| 06/25/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/21/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Diagnostic Imaging | ||||||
| 06/11/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/28/2021 | Medtronic, Inc. | IN.PACT Admiral (Device) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Drug-Coated Balloons | ||||||
| 02/25/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/03/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Diagnostic Imaging | ||||||
| 01/18/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: HORMONE THERAPY | ||||||
| 01/12/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/19/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: UROLOGY | ||||||
| 09/22/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: UROLOGY | ||||||
| 11/14/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/14/2019 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Diagnostic Imaging | ||||||
| 10/08/2019 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Bone Health | ||||||
| 09/12/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $110.56 | General |
| Category: UROLOGY | ||||||
| 07/02/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: UROLOGY | ||||||
| 06/12/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: UROLOGY | ||||||
| 03/14/2019 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: UROLOGY | ||||||
| 03/04/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: UROLOGY | ||||||
| 11/26/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/20/2018 | Avadel Specialty Pharmaceuticals, LLC | Noctiva (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 31 | 2,671 | 5,165 | $369,878 | $110,452 |
| 2021 | 32 | 2,981 | 5,620 | $375,133 | $114,293 |
| 2020 | 39 | 3,002 | 6,119 | $469,877 | $126,137 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 319 | 454 | $113,500 | $36,088 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 385 | 556 | $94,520 | $31,492 | 33.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2022 | 264 | 401 | $28,872 | $7,276 | 25.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 21 | 21 | $10,164 | $4,110 | 40.4% |
| 84403 | Testosterone (hormone) level, total | Office | 2022 | 89 | 132 | $9,636 | $3,361 | 34.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 295 | 496 | $19,840 | $3,190 | 16.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 82 | $8,282 | $3,128 | 37.8% |
| 87210 | Smear for infectious agents | Office | 2022 | 304 | 460 | $5,520 | $2,628 | 47.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2022 | 21 | 21 | $5,292 | $2,430 | 45.9% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2022 | 26 | 31 | $8,305 | $2,260 | 27.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2022 | 11 | 11 | $6,908 | $2,045 | 29.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 229 | $8,931 | $2,044 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $8,283 | $1,710 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $4,008 | $1,614 | 40.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 20 | 21 | $11,200 | $1,162 | 10.4% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 43 | 59 | $3,717 | $1,126 | 30.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 284 | 432 | $3,024 | $947.34 | 31.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 169 | 269 | $2,959 | $839.82 | 28.4% |
| 86316 | Analysis for detection of tumor marker | Office | 2022 | 27 | 27 | $2,160 | $554.10 | 25.7% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2022 | 27 | 27 | $2,025 | $489.71 | 24.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 11 | 13 | $994.00 | $377.12 | 37.9% |
| 87086 | Bacterial colony count, urine | Office | 2022 | 30 | 43 | $1,892 | $343.17 | 18.1% |
| 87088 | Bacterial urine culture | Office | 2022 | 17 | 34 | $680.00 | $272.10 | 40.0% |
| 87184 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | Office | 2022 | 17 | 33 | $660.00 | $244.17 | 37.0% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2022 | 21 | 21 | $5,019 | $205.65 | 4.1% |
About Dr. Claude Workman, MD
Dr. Claude Workman, MD is a Urology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205814746.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Claude Workman, MD has received a total of $1,773 in payments from pharmaceutical and medical device companies, with $19.91 received in 2023. These payments were reported across 99 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,773).
As a Medicare-enrolled provider, Workman has provided services to 8,654 Medicare beneficiaries, totaling 16,904 services with total Medicare billing of $350,882. Data is available for 3 years (2020–2022), covering 102 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Nashville, TN
- Active Since 01/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1205814746
Products in Payments
- MYRBETRIQ (Drug) $225.86
- Myrbetriq (Drug) $177.76
- FIRMAGON (Drug) $145.32
- XTANDI (Drug) $126.03
- KEYTRUDA (Biological) $115.22
- JELMYTO (Drug) $110.51
- PROVENGE (Drug) $99.60
- PREMARIN (Drug) $88.10
- Xofigo (Drug) $80.97
- BOTOX (Biological) $79.69
- Axumin (Drug) $72.74
- GEMTESA (Drug) $70.14
- Prolia (Biological) $69.25
- ELIGARD (Drug) $59.74
- VESICARE (Drug) $43.99
- Trulance (Drug) $42.48
- Noctiva (Drug) $36.67
- ORGOVYX (Drug) $25.91
- Natesto (Drug) $24.43
- XIAFLEX (Biological) $18.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Nashville
L Knoll, Md, MD
Urology — Payments: $2.5M
Dr. Gautam Jayram, Md, MD
Urology — Payments: $849,729
Roger Dmochowski, Md, MD
Urology — Payments: $822,773
Raoul Concepcion, Md, MD
Urology — Payments: $611,502
Dr. Ashley Tapscott, D.o, D.O
Urology — Payments: $576,883
Melissa Kaufman, Md, MD
Urology — Payments: $340,012